https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-pay-245-mln-over-exforge-drug-generics-2022-12-29/
0
0
12/29/22 at 1:24am
Organization
Reuters
Authors
Novartis AG <a href="https://www.reuters.com/companies/NOVN.S" target="_blank">(NOVN.S)</a> said on Wednesday it will pay $245 million to end antitrust litigation accusing the Swiss drugmaker of trying to delay the launch in the United States of generic versi…
Create an account
or login to join the discussion